Trial Profile
Real life outcomes of rabbit ATG (Thymoglobulin, SANOFI) treated as a first line treatment for Aplastic Anemia in Europe and Asia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Aplastic anaemia
- Focus Therapeutic Use
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology